3 Sanofians in Brazil, talking in sign language

3 Sanofians in Brazil, talking in sign language

3 Sanofians in Brazil, talking in sign language

Disability Inclusion In Action

At Sanofi, we are committed to accessibility and disability inclusion through a holistic and best-in-class approach.

Digital at Sanofi

Digital is at the heart of our ambition to transform the practice of medicine. We take never-been-done before & make it reality. And we’re just getting started.

Fighting for Inclusion: "My disability won't stop me"

Athletes Ezra Frech, Nantenin Keita and Davide Morana don’t compete in the same category, but they all have something in common: they have overcome their disability and are now fulfilling their potential through their sporting careers.

Partner Spotlight: Kymera and Sanofi chase “undruggable” targets in immunology

Targeted protein degradation is an investigational new treatment approach that may have major implications in the immunology and inflammation space.

Sanofi Impulsions 2024

Discover Sanofi Impulsion 2024, a series of events that bridge science and sport to advance society. 

Kids & Diabetes in Schools – Celebrating 10 Years of Impact

Since 2013, Sanofi has partnered with the International Diabetes Federation and the International Society for Pediatric and Adolescent Diabetes to deliver KiDS – Kids & Diabetes in Schools.

Sanofi R&D Launches a New Call for Innovative Proposals

The iDEA-iTECH initiative funds university and early startup collaborations to advance cutting-edge science & technologies. Pre-proposals due by December 15, 2023. 

Sanofi Today

Dany Dann and Ezra Frech, World para athletics 2023

Paris 2024 Partnership

December 1, 2023

Fighting for Inclusion: "My disability won't stop me from achieving victory"

Our latest news

December 1, 2023
Press Release: Sanofi’s Consumer Healthcare unit launches the Shared Care Collective, an advisory group working to advance sustainability
November 27, 2023
Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious disease
November 9, 2023
Media Update: Sanofi completes closing for potential first-in-class vaccine against extraintestinal pathogenic E.coli (ExPEC)
October 27, 2023
Press Release: Specialty Care growth, strong launch uptake of Beyfortus® and ALTUVIIIO® drive solid Q3 results

Explore More

Diversity, Equity, and Inclusion Report

In the first full year of our new People and Culture strategy, Diversity, Equity, and Inclusion took center stage. This report celebrates the tangible progress we’ve made towards reflecting diversity in our leadership, unleashing the full potential of our people, and achieving impact in and beyond the workplace.

Our Legacy

Our company of today is built on a heritage of turning the impossible into the possible.

Our Integrated Report 2022

Discover how we’re making the impossible possible to improve people's lives everywhere.

Explore Career Opportunities

You'll be surprised what you can achieve at Sanofi. Discover your future here.